U3O8 Corp announces the terms of a private placement that is being made available to its existing shareholders through the Existing Shareholder Prospectus Exemption (“ESPE”) that was adopted by the Toronto Stock Exchange (“TSX”) in 2015.
Toronto, Ontario – June 23, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) reports that all matters brought before its shareholders were approved at the Annual & Special Meeting (“ASM”) held yesterday in Toronto, Ontario. A total of 121,790,106 of the Corporation’s common shares were voted, representing 35% of its issued and outstanding stock. In addition, 19.3 million warrants expired and 2.85 million warrants were exercised for gross proceeds of $99,750, which together reduce the number of outstanding warrants by approximately 18%.
Five operating reactors: The Takahama 3 unit that was brought back into operation on June 6th, is the 5th reactor to be re-started in Japan as the country gradually ramps up nuclear electricity generation. The re-start of Takahama 3 follows the Takahama 4 unit that was brought back on-line in May and reached full commercial production yesterday. Takahama 3 was connected to the electricity grid on June 9th and is scheduled to reach full power output in early-July. The other three reactors that are operating in Japan are Sendai 1 & 2 and Ikata 3.
Toronto, Ontario – June 6, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) is pleased to announce that, as part of the capital restructuring spearheaded by the proposed share consolidation to be voted upon at the Annual and Special Meeting to be held on June 22, 2017, it has reached agreement with a shareholder to reprice and accelerate an aggregate total of 19.3 million previously issued common share purchase warrants (the “Warrants’). In addition, Dr. Keith Barron, founder and director of U3O8 Corp., has offered to exercise out-of-the-money warrants as a means of providing the Company with working capital that is not dilutive to U3O8 Corp. shareholders.
Latest Press Releases
- U3O8 Corp to Resume TradingApril 27, 2020 - 12:01 pm
- U3O8 Corp. Announces the Termination of the Binding Letter of Intent with Diagnostic Lab Corporation, Inc. and Postpones Reporting of Fourth Quarter and 2019 Full-Year Reporting Due to Delays Caused by COVID-19 PandemicMarch 30, 2020 - 10:53 am
- U3O8 Corp Announces Proposed Reverse Takeover Transaction With Diagnostic Lab Corporation, Inc.March 3, 2020 - 9:00 am
- U3O8 Corp Updates on Transfer to NEX BoardFebruary 25, 2020 - 9:00 am